428.15MMarket Cap-4494P/E (TTM)
8.050High7.780Low460.67KVolume7.940Open7.990Pre Close3.66MTurnover1.29%Turnover RatioLossP/E (Static)53.52MShares30.99052wk High1.88P/B286.84MFloat Cap5.67052wk Low--Dividend TTM35.86MShs Float72.200Historical High--Div YieldTTM3.38%Amplitude2.190Historical Low7.936Avg Price1Lot Size
EyePoint Pharmaceuticals Stock Forum
NEWS
EyePoint Pharmaceuticals Trial of Duravyu in Diabetic Eye Disease Fails to Meet Primary Endpoint
Larger Image: tradingview.com...
$EyePoint Pharmaceuticals (EYPT.US)$
$EyePoint Pharmaceuticals (EYPT.US)$
$Adverum Biotechnologies (ADVM.US)$
$Regenxbio (RGNX.US)$
$4D Molecular Therapeutics (FDMT.US)$
$Kodiak Sciences (KOD.US)$
📊⚡️📊
No comment yet